The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Stuart Weisman
Palo Alto, California, United States
University of Colorado Medical Center
Denver, Colorado, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mark Lamet
Hollywood, Florida, United States
Wayne Schonfeld
Hollywood, Florida, United States
Mount Sinai Medical Center
Miami Beach, Florida, United States
University of Chicago Hospital Medical Center
Chicago, Illinois, United States
Gerald Dryden
Louisville, Kentucky, United States
Richard MacDermott
Albany, New York, United States
Hillary Steinhart
Toronto, Ontario, Canada
...and 1 more locations